The estimated Net Worth of Andrew Makrides is at least $944 millier dollars as of 5 July 2022. Mr. Makrides owns over 30,000 units of Apyx Medical stock worth over $803,845 and over the last 7 years he sold APYX stock worth over $0. In addition, he makes $139,868 as Independent Chairman of the Board at Apyx Medical.
Andrew has made over 1 trades of the Apyx Medical stock since 2022, according to the Form 4 filled with the SEC. Most recently he exercised 30,000 units of APYX stock worth $76,200 on 5 July 2022.
The largest trade he's ever made was exercising 30,000 units of Apyx Medical stock on 5 July 2022 worth over $76,200. On average, Andrew trades about 3,333 units every 0 days since 2017. As of 5 July 2022 he still owns at least 637,972 units of Apyx Medical stock.
You can see the complete history of Mr. Makrides stock trades at the bottom of the page.
Andrew Makrides Esq. J.D. serves as Independent Chairman of the Board of the Company. Mr. Makrides received a Bachelor of Arts degree in Psychology from Hofstra University and a Juris Doctor Degree from Brooklyn Law School. He is a member of the Bar of the State of New York and practiced law from 1968 until joining Apyx Medical Corporation as a co-founder and Executive Vice President and director, in 1982. Mr. Makrides became President of the Company in 1985 and the CEO in December 1998 and served as such until March 18, 2011 at which point he relinquished his position as President, but remained CEO until December 2013. Mr. Makrides employment contract expired December 31, 2016. Mr. Makrides has over 30 years of executive experience in the medical industry. The Company believes Mr. Makrides is qualified to serve as Chairman because of his over 30 years of experience in the medical device industry as well as with his previous tenure with the Company.
As the Independent Chairman of the Board of Apyx Medical, the total compensation of Andrew Makrides at Apyx Medical is $139,868. There are 10 executives at Apyx Medical getting paid more, with Charles Goodwin having the highest compensation of $1,945,260.
Andrew Makrides is 78, he's been the Independent Chairman of the Board of Apyx Medical since 2017. There are no older and 12 younger executives at Apyx Medical.
Andrew's mailing address filed with the SEC is C/O APYX MEDICAL CORPORATION, 5115 ULMERTON ROAD, CLEARWATER, FL, 33760.
Over the last 6 years, insiders at Apyx Medical have traded over $0 worth of Apyx Medical stock and bought 97,836 units worth $253,260 . The most active insiders traders include Stavros G. Vizirgianakis, Charles D. Ii Goodwin et Moshe Citronowicz. On average, Apyx Medical executives and independent directors trade stock every 86 days with the average trade being worth of $18,719. The most recent stock trade was executed by Matthew C Hill on 13 August 2024, trading 5,336 units of APYX stock currently worth $6,030.
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and OEM. It offers electrosurgical generators based on its Helium Plasma Technology for cutting, coagulation, and ablation of soft tissue. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market that allows surgeons to operate with precision and eliminate unintended tissue trauma. It also develops, manufactures, and sells energy generators, disposable hand piece subassemblies, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Apyx Medical executives and other stock owners filed with the SEC include: